GHK-Cu + Zinc Thymulin (Duo)
Synthetic peptide studied in animal and cell models for skin matrix remodeling and hair follicle cycle optimization
Last updated: March 1, 2026
- Compound
- GHK-Cu + Zinc Thymulin (Duo)
- Class
- Longevity peptide
- Summary
- Synthetic peptide studied in animal and cell models for skin matrix remodeling, hair follicle cycle optimization, anti-inflammatory & antioxidant protection.
- Mechanism
- Angiogenic & Nutritional Support
- Research Status
- Preclinical
- Routes Studied
- Topical application
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About GHK-Cu + Zinc Thymulin (Duo)?
- What is GHK-Cu + Zinc Thymulin (Duo)?
- GHK-Cu + Zinc Thymulin (Duo) is a synthetic peptide studied in animal and cell models for skin matrix remodeling and hair follicle cycle optimization.
- Is GHK-Cu + Zinc Thymulin (Duo) clinically proven?
- No. Human evidence remains limited and does not establish GHK-Cu + Zinc Thymulin (Duo) as clinically proven.
- What has GHK-Cu + Zinc Thymulin (Duo) been studied for?
- GHK-Cu + Zinc Thymulin (Duo) has been studied in preclinical models of skin matrix remodeling, hair follicle cycle optimization, anti-inflammatory & antioxidant protection. These findings have not been confirmed in large-scale human trials.
- Is GHK-Cu + Zinc Thymulin (Duo) approved?
- No. GHK-Cu + Zinc Thymulin (Duo) is not an approved drug and remains a research compound.
What Is GHK-Cu + Zinc Thymulin (Duo)?
GHK-Cu + Zinc Thymulin (Duo) is a topical formulation combining two biologically active peptide complexes that target complementary aspects of skin regeneration and hair follicle biology. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper chelate first isolated from human plasma by Dr. Loren Pickart in 1973, while Zinc Thymulin (Zinc-bound Thymulin, also known as Facteur Thymique Serique or FTS-Zn) is a zinc-dependent nonapeptide originally identified as a thymic hormone...
Evidence Summary
GHK-Cu + Zinc Thymulin (Duo) has preliminary preclinical evidence only. Human clinical trial data is not available.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Skin Matrix Remodeling | Insufficient |
| Hair Follicle Cycle Optimization | Insufficient |
| Anti-Inflammatory & Antioxidant Protection | Insufficient |
| DHT Modulation | Insufficient |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
Editorial Position
GHK-Cu + Zinc Thymulin (Duo) is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for GHK-Cu + Zinc Thymulin (Duo) is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has GHK-Cu + Zinc Thymulin (Duo) Been Studied For?
Research areas where GHK-Cu + Zinc Thymulin (Duo) has been investigated in published studies
-
Skin Matrix Remodeling GHK-Cu + Zinc Thymulin (Duo) has been studied in animal models of skin matrix remodeling. These findings have not been confirmed in controlled human trials.
-
Hair Follicle Cycle Optimization GHK-Cu + Zinc Thymulin (Duo) has been studied in animal models of hair follicle cycle optimization. These findings have not been confirmed in controlled human trials.
-
Anti-Inflammatory & Antioxidant Protection GHK-Cu + Zinc Thymulin (Duo) has been studied in animal models of anti-inflammatory & antioxidant protection. These findings have not been confirmed in controlled human trials.
-
DHT Modulation GHK-Cu + Zinc Thymulin (Duo) has been studied in animal models of dht modulation. These findings have not been confirmed in controlled human trials.
How Does GHK-Cu + Zinc Thymulin (Duo) Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 GHK-Cu Gene Modulation & Matrix Synthesis
- 02 Anti-Inflammatory & Antioxidant Environment
- 03 Zinc Thymulin TGF-beta2 Suppression
- 04 5-Alpha-Reductase Modulation
Not sure if GHK-Cu + Zinc Thymulin (Duo) is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about GHK-Cu + Zinc Thymulin (Duo).
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate GHK-Cu + Zinc Thymulin (Duo)
How Is GHK-Cu + Zinc Thymulin (Duo) Administered?
GHK-Cu + Zinc Thymulin (Duo) is available via Topical application. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of GHK-Cu + Zinc Thymulin (Duo)?
What Conditions Has GHK-Cu + Zinc Thymulin (Duo) Been Linked To?
Have Questions About GHK-Cu + Zinc Thymulin (Duo)?
GHK-Cu (glycyl-histidyl-lysine copper complex) is a naturally occurring tripeptide-copper chelate found in human plasma, saliva, and urine. It modulates the expression of thousands of genes involved in matrix synthesis, inflammation, and antioxidant defense.
Yes. The formulation is designed for application to both facial skin and scalp. For facial use, the GHK-Cu component provides primary benefits through matrix remodeling and antioxidant protection.
Individuals with copper metabolism disorders (Wilson's disease) should not use GHK-Cu-containing products without medical clearance. Those with known metal allergies should perform a patch test before full application.
Ready to discuss GHK-Cu + Zinc Thymulin (Duo) with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026